Table 1.
Demographics and baseline characterizations
|
ABP 959 (N = 71) |
Eculizumab US (N = 72) |
Eculizumab EU (N = 74) |
|
|---|---|---|---|
| Age, years | |||
| Mean (SD) | 27.0 (6.35) | 26.7 (5.52) | 26.9 (6.47) |
| Race, n (%) | |||
| Asian (first‐generation Japanese) | 4 (5.6) | 4 (5.6) | 4 (5.4) |
| Asian (other) | 11 (15.5) | 15 (20.8) | 19 (25.7) |
| Black or African American | 1 (1.4) | 3 (4.2) | 3 (4.1) |
| White | 51 (71.8) | 47 (65.3) | 45 (60.8) |
| Other | 4 (5.6) | 3 (4.2) | 3 (4.1) |
| Sex, n (%) | |||
| Male | 71 (100.0) | 72 (100.0) | 74 (100.0) |
| Weight (kg), Mean (SD) | 74.74 (8.93) | 71.67 (9.04) | 71.76 (7.98) |
| Height (cm), Mean (SD) | 177.3 (6.90) | 176.0 (5.99) | 176.1 (7.45) |
| Body mass index (kg/m2), Mean (SD) | 23.75 (2.33) | 23.12 (2.57) | 23.13 (2.23) |
Abbreviation: SD, standard deviation.